FN1 and neoplasm: Platelet–tumor cell aggregates form through binding of platelet integrin αIIbβ3 to tumor cell integrin αvβ3 via RGD-containing proteins including fibrinogen, von Willebrand factor, and fibronectin, a process known as tumor cell-induced platelet aggregation (TCIPA) (10).